|
|
Volumn 16, Issue 4, 2016, Pages 1332-1333
|
|
Checkpoint Inhibitors in Kidney Transplant Recipients and the Potential Risk of Rejection
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CARBOPLATIN;
CYCLOSPORIN;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY;
IPILIMUMAB;
METHYLPREDNISOLONE;
PACLITAXEL;
PEMBROLIZUMAB;
PREDNISONE;
PROGRAMMED DEATH 1 RECEPTOR ANTIBODY;
RECEPTOR ANTIBODY;
TACROLIMUS;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC AGENT;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
PDCD1 PROTEIN, HUMAN;
PROGRAMMED DEATH 1 RECEPTOR;
AGED;
BONE METASTASIS;
CANCER REGRESSION;
CASE REPORT;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
CUTANEOUS MELANOMA;
GRAFT RECIPIENT;
HEMODIALYSIS;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
INGUINAL LYMPH NODE;
KIDNEY BIOPSY;
KIDNEY DISEASE;
KIDNEY FUNCTION;
KIDNEY GRAFT;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LETTER;
LOW DRUG DOSE;
LUNG METASTASIS;
LYMPH NODE BIOPSY;
MALE;
METASTATIC MELANOMA;
PRIORITY JOURNAL;
SKIN CANCER;
SQUAMOUS CELL CARCINOMA;
T LYMPHOCYTE;
TREATMENT RESPONSE;
ADVERSE EFFECTS;
ANTAGONISTS AND INHIBITORS;
COMPLICATION;
GRAFT REJECTION;
GRAFT SURVIVAL;
KIDNEY FAILURE, CHRONIC;
MELANOMA;
PATHOLOGY;
POSTOPERATIVE COMPLICATION;
PROGNOSIS;
RISK FACTOR;
SECONDARY;
SKIN NEOPLASMS;
AGED;
ANTINEOPLASTIC AGENTS;
CTLA-4 ANTIGEN;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
MALE;
MELANOMA;
POSTOPERATIVE COMPLICATIONS;
PROGNOSIS;
PROGRAMMED CELL DEATH 1 RECEPTOR;
RISK FACTORS;
SKIN NEOPLASMS;
TRANSPLANT RECIPIENTS;
|
|
EID: 84961878509
PISSN: 16006135
EISSN: 16006143
Source Type: Journal
DOI: 10.1111/ajt.13711 Document Type: Letter |
|
Times cited : (103)
|
|
References (5)
|
